# 04_QA_REPORT.md

# Quality Assurance Report

## Identity

| Field | Value |
|---|---|
| QA Report ID | QA-PP-0228 |
| PP ID | PP-0228 |
| Title | Best Supportive Care |
| Version | 1.0.0 |
| Status | PASS — GOLD |
| QA Mode | Four-layer substantive QA |
| Source-First | PASS |
| Locked Decision Integrity | PASS |

---

# 1. Executive QA Decision

# PASS — GOLD

PP-0228 is consistent with the approved and locked Decision Batch.

The package preserves:

- BSC as an active supportive-care layer;
- longitudinal supportive-care applicability;
- concurrent use with anticancer treatment;
- symptom-oriented clinical reasoning;
- bleeding and obstruction domains;
- nutrition/hydration;
- function/rehabilitation;
- psychosocial/caregiver support;
- reassessment;
- multidisciplinary principle;
- PP-0227 boundary;
- PP-0208 boundary;
- PP-0231 boundary;
- evidence traceability;
- Knowledge Graph;
- patient-facing education;
- Gold artifact structure and depth.

No material blocker identified.

---

# 2. Layer 1 — Content QA

## 2.1 Scope Compliance

### Required

PP-0228 must explain:

- BSC definition;
- active supportive-care role;
- symptom assessment;
- major gastric-cancer supportive problems;
- intervention categories;
- concurrent treatment;
- nutrition/function/psychosocial support;
- reassessment;
- patient interpretation.

### Assessment

**PASS**

---

## 2.2 Atomicity

PP-0228 is one clinical knowledge unit:

> **Best Supportive Care**

It does not become:

- a palliative-care philosophy package;
- a systemic-treatment package;
- a toxicity package;
- a procedure manual;
- a hospice-administration package.

### Assessment

**PASS**

---

## 2.3 Completeness

The CKO contains:

- objectives;
- scope;
- clinical knowledge blocks;
- symptom domains;
- patient explanation;
- misconceptions;
- patient questions;
- safety;
- evidence maturity;
- Knowledge Graph;
- boundary.

### Assessment

**PASS**

---

## 2.4 Internal Consistency

All four artifacts consistently state:

- BSC is active care;
- BSC can coexist with treatment;
- BSC is needs-driven;
- assessment precedes intervention;
- intervention choice is context-dependent;
- PP-0227 owns palliative framework;
- PP-0231 owns detailed treatment toxicity;
- PP-0208 owns systemic therapy.

### Assessment

**PASS**

---

# 3. Layer 2 — Clinical QA

## 3.1 NCCN BSC Alignment

The package correctly reflects the supplied NCCN GAST-J content:

- prevent/relieve suffering;
- support quality of life;
- patients and families;
- regardless of stage;
- regardless of other therapies;
- multidisciplinary approach.

### Assessment

**PASS**

---

## 3.2 Bleeding Alignment

The package correctly includes:

- acute severe bleeding;
- prompt assessment;
- endoscopic assessment;
- possible endoscopic treatment;
- interventional radiology/embolization;
- radiation;
- selected palliative surgery;
- recurrent bleeding limitation.

### Assessment

**PASS**

---

## 3.3 Obstruction Alignment

The package correctly includes:

- nausea/vomiting;
- oral-intake restoration goal;
- endoscopic options;
- surgical options;
- decompression;
- nutritional support;
- individualized choice.

### Assessment

**PASS**

---

## 3.4 Symptom Assessment

The package does not assume a single cause for symptoms.

It explicitly uses:

**symptom → assessment → cause → intervention → reassessment**

### Assessment

**PASS**

---

## 3.5 Nutrition Alignment

The package correctly treats nutrition as a major supportive-care domain and does not create an individualized nutritional prescription.

### Assessment

**PASS**

---

## 3.6 Psychosocial Alignment

Psychosocial and caregiver needs are included without turning PP-0228 into a dedicated psychiatric treatment package.

### Assessment

**PASS**

---

## 3.7 Rehabilitation Alignment

Function and rehabilitation are included at framework level.

Detailed rehabilitation remains delegated.

### Assessment

**PASS**

---

## 3.8 Concurrent Therapy Alignment

The package correctly states that BSC can be delivered with active anticancer treatment.

### Assessment

**PASS**

---

# 4. Clinical Safety Review

## Rule 1 — No individualized treatment

**PASS**

## Rule 2 — No medication dosing

**PASS**

## Rule 3 — No procedural instructions

**PASS**

## Rule 4 — No individualized prognosis

**PASS**

## Rule 5 — No hospice eligibility

**PASS**

## Rule 6 — No universal intervention algorithm

**PASS**

## Rule 7 — Acute symptoms require appropriate assessment

**PASS**

---

# 5. Layer 3 — Educational QA

## 5.1 Patient-Facing Clarity

The package explains:

- BSC is active care;
- BSC is not giving up;
- BSC can coexist with cancer treatment;
- BSC can include procedures;
- BSC is individualized.

### Assessment

**PASS**

---

## 5.2 Terminology

The following are explained:

- Best Supportive Care;
- palliative care;
- symptom burden;
- malignant obstruction;
- supportive intervention;
- treatment burden;
- rehabilitation;
- multidisciplinary care.

### Assessment

**PASS**

---

## 5.3 Misconception Control

The package addresses:

- BSC = no treatment;
- BSC = terminal care;
- BSC = treatment cessation;
- BSC = pain medication;
- BSC = no procedures;
- every obstruction is treated the same;
- all nausea is chemotherapy-related;
- nutrition = forced feeding;
- BSC begins only after treatment failure.

### Assessment

**PASS**

---

## 5.4 Logical Flow

The CKO follows:

**Definition**

→ **active-care role**

→ **assessment model**

→ **bleeding**

→ **obstruction**

→ **nausea/vomiting**

→ **pain**

→ **fatigue**

→ **nutrition**

→ **hydration**

→ **function**

→ **psychosocial care**

→ **reassessment**

→ **patient interpretation**

This is appropriate for the intervention-oriented BSC package.

### Assessment

**PASS**

---

# 6. Layer 4 — Governance QA

## 6.1 Source-First

PP-specific source search was performed before production.

Primary clinical evidence is anchored to:

- NCCN Gastric Cancer v2.2026;
- ESMO-ASCO 2023;
- NCI Gastric Cancer Treatment PDQ;
- ACS Stomach Cancer.

### Assessment

**PASS**

---

## 6.2 User-Controlled Sequence

The package produced is exactly the explicitly requested PP:

**PP-0228 — Best Supportive Care**

No automatic transition to PP-0229.

### Assessment

**PASS**

---

## 6.3 Approved Decision Integrity

The artifacts implement the approved Decision Batch without reopening or changing its scope.

### Assessment

**PASS**

---

## 6.4 Gold Structure

Required artifacts:

- CKO;
- Knowledge Passport;
- Primary Evidence Package;
- QA Report.

All are present.

### Assessment

**PASS**

---

# 7. Gold Depth Integrity Review

## Golden Rule

Gold reference depth is the minimum standard.

The artifacts must not be:

- shortened;
- compacted;
- summarized;
- reduced in clinical reasoning;
- reduced in evidence traceability;
- reduced in Knowledge Graph depth;
- reduced in patient-facing depth;
- reduced in QA depth.

### Assessment

**PASS**

---

## CKO Depth

The CKO includes:

- detailed objectives;
- full scope;
- clinical reasoning;
- symptom-specific supportive domains;
- patient-facing content;
- misconceptions;
- safety;
- evidence maturity;
- Knowledge Graph;
- four-part Boundary.

**PASS**

---

## Knowledge Passport Depth

The KP includes:

- identity;
- classification;
- clinical question;
- knowledge units;
- runtime;
- retrieval vocabulary;
- patient journey;
- evidence classification;
- source passport;
- evidence-to-runtime mapping;
- boundary map;
- graph;
- runtime rules;
- version control.

**PASS**

---

## Evidence Package Depth

The EP includes:

- clinical question;
- evidence intent;
- source hierarchy;
- evidence matrix;
- detailed appraisal;
- clinical use model;
- problem-by-problem evidence;
- consistency review;
- limitations;
- gaps;
- patient translation;
- source traceability;
- adjacent-boundary verification;
- Knowledge Graph;
- update triggers.

**PASS**

---

## QA Depth

The QA includes:

- content QA;
- clinical QA;
- educational QA;
- governance QA;
- safety;
- misconception control;
- overlap;
- evidence traceability;
- numerical evidence review;
- Knowledge Graph;
- Gold-depth integrity;
- package integrity.

**PASS**

---

# 8. Adjacent PP Overlap Audit

## PP-0227 — Palliative Care

### PP-0227 owns

- palliative-care framework;
- philosophy;
- goals of care;
- advance care planning;
- end-of-life;
- hospice interface.

### PP-0228 owns

- practical supportive-care intervention framework.

### Result

# PASS — PRIMARY BOUNDARY VERIFIED

---

## PP-0208 — Palliative Systemic Therapy

### PP-0208 owns

- systemic anticancer therapy.

### PP-0228 owns

- supportive care surrounding treatment.

### Result

**PASS**

---

## PP-0231 — Treatment-related Toxicity and Supportive Care

### PP-0231 owns

- treatment-specific toxicity.

### PP-0228 owns

- general symptom/supportive-care layer.

### Result

# PASS — TOXICITY BOUNDARY VERIFIED

---

## PP-0232 — Multidisciplinary Management

### PP-0232 owns

- operational MDT management.

### PP-0228 owns

- multidisciplinary supportive-care principle.

### Result

**PASS**

---

## PP-0222 / PP-0223

Disease packages own recurrence/metastatic disease.

PP-0228 owns supportive burden.

### Result

**PASS**

---

## PP-0224 / PP-0225 / PP-0226

Disease/procedural packages own peritoneal disease and HIPEC.

PP-0228 owns supportive-care consequences.

### Result

**PASS**

---

# 9. Evidence Traceability Audit

| Claim | Source | Status |
|---|---|---|
| BSC purpose | NCCN | PASS |
| Quality of life | NCCN | PASS |
| Patient/family focus | NCCN | PASS |
| Multidisciplinary care | NCCN/ESMO-ASCO | PASS |
| Bleeding | NCCN | PASS |
| Obstruction | NCCN | PASS |
| Symptom assessment | ESMO-ASCO | PASS |
| Nutrition | ESMO-ASCO | PASS |
| Rehabilitation | ESMO-ASCO | PASS |
| Psychosocial care | ESMO-ASCO | PASS |
| Concurrent systemic therapy | NCCN | PASS |
| Palliative intervention interface | NCCN/NCI | PASS |
| Patient translation | ACS | PASS |

---

# 10. Numerical Evidence Audit

The package does not introduce unsupported individualized thresholds.

Where NCCN performance-status context is discussed, it is presented as guideline context rather than a stand-alone individualized treatment rule.

No individualized survival estimate is provided.

### Assessment

**PASS**

---

# 11. Knowledge Graph Audit

## Prerequisites

- PP-0227;
- PP-0222;
- PP-0223;
- relevant treatment knowledge.

## Related

- PP-0208;
- PP-0224;
- PP-0225;
- PP-0226;
- PP-0231;
- PP-0232;
- nutrition;
- rehabilitation;
- psychosocial care.

## Downstream

Potential dedicated supportive domains are identified without inventing package IDs.

### Assessment

**PASS**

---

# 12. Boundary Integrity Audit

## Core

Practical BSC management layer.

**PASS**

## Supporting

Disease/treatment context necessary for supportive-care interpretation.

**PASS**

## Explicitly Excluded

Detailed specialty procedures, pharmacology, systemic therapy, toxicity algorithms and individualized decisions.

**PASS**

## Delegated-to PP

Adjacent package ownership explicitly identified.

**PASS**

---

# 13. Cross-Artifact Consistency

| Dimension | CKO | KP | EP | QA |
|---|---|---|---|---|
| BSC definition | PASS | PASS | PASS | PASS |
| Active-care concept | PASS | PASS | PASS | PASS |
| Symptom assessment | PASS | PASS | PASS | PASS |
| Bleeding | PASS | PASS | PASS | PASS |
| Obstruction | PASS | PASS | PASS | PASS |
| Nutrition | PASS | PASS | PASS | PASS |
| Function | PASS | PASS | PASS | PASS |
| Psychosocial support | PASS | PASS | PASS | PASS |
| Concurrent therapy | PASS | PASS | PASS | PASS |
| PP-0227 boundary | PASS | PASS | PASS | PASS |
| PP-0208 boundary | PASS | PASS | PASS | PASS |
| PP-0231 boundary | PASS | PASS | PASS | PASS |
| Safety | PASS | PASS | PASS | PASS |
| Knowledge Graph | PASS | PASS | PASS | PASS |

### Overall

**PASS**

---

# 14. Package Integrity

Expected:

```text
PP-0228_Best_Supportive_Care_GOLD_v1.0.0/
├── 01_CKO.md
├── 02_KNOWLEDGE_PASSPORT.md
├── 03_PRIMARY_EVIDENCE_PACKAGE.md
└── 04_QA_REPORT.md
```

### Assessment

**PASS**

---

# 15. Final QA Matrix

| QA Dimension | Status |
|---|---|
| Content QA | PASS |
| Clinical QA | PASS |
| Educational QA | PASS |
| Governance QA | PASS |
| Clinical Safety Review | PASS |
| Patient Misconception Review | PASS |
| Adjacent PP Overlap Audit | PASS |
| Evidence Traceability Audit | PASS |
| Numerical Evidence Audit | PASS |
| Knowledge Graph Audit | PASS |
| Gold Depth Integrity Review | PASS |
| Source-First Audit | PASS |
| Locked Decision Integrity | PASS |
| Cross-Artifact Consistency | PASS |
| Boundary Integrity | PASS |
| Package Integrity | PASS |

---

# 16. Final QA Status

# PASS — GOLD — READY FOR INTEGRATION

---

# Revision History

| Version | Date | Summary |
|---|---|---|
| 1.0.0 | 2026-08-09 | Initial Gold QA after approved PP-0228 Decision Batch |
